Individualized care and patient satisfaction are among the areas of emphasis in a new consensus statement on management of thyroid eye disease.
A task force consisting of members from the American Thyroid Association and the European Thyroid Association (ETA) crafted the statement with the goal of giving state-of-the-art advice to general endocrinologists who treat the disease, according to Henry B. Burch, MD, co-chair of the task force, program director in the division of diabetes, endocrinology and metabolic diseases at the NIH’s National Institute of Diabetes and Digestive and Kidney